Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (csc) diagnosed by swept source optical coherence tomography angiography (ss octa)
International Journal of Development Research
Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (csc) diagnosed by swept source optical coherence tomography angiography (ss octa)
Received 10th June, 2019; Received in revised form 15th July, 2019; Accepted 19th August, 2019; Published online 30th September, 2019.
Copyright © 2019, Dan Călugăru and Mihai Călugăru. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The authors are commenting on the study entitled “Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA)” published in Graefes Archive for Clinical and Experimental Ophthalmology 2019; 257(8):1581-1590. This study concluded that clinical evaluation of neovascular and non-neovascularchronic serous chorioretinopathy revealed a significant difference between the age of chronic central serous chorioretinopathy patients (69 and 47 years, respectively) and a significant differentiation according to distance and reading visual acuity outcomes with better intial and final values for non-neovascular chronic central serous chorioretinopathy eyes. Conceivably, the number of these clinical findings would have been higher if all the missing data mentioned by us had been included in statistical analyses in addition to the baseline characteristics already assessed in this study, serving to identify the key drivers correlated with final visual acuity and resolution of subretinal fluid after treatment.
